ES8507536A1 - Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas. - Google Patents
Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas.Info
- Publication number
- ES8507536A1 ES8507536A1 ES534824A ES534824A ES8507536A1 ES 8507536 A1 ES8507536 A1 ES 8507536A1 ES 534824 A ES534824 A ES 534824A ES 534824 A ES534824 A ES 534824A ES 8507536 A1 ES8507536 A1 ES 8507536A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- reaction
- compound
- quinazoline
- cardiac stimulants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE QUINAZOLINA, Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X E Y PUEDEN SER VARIOS TIPOS DE RADICALES; COMPUESTOS QUE TIENEN APLICACIONES FARMACOLOGICAS COMO ESTIMULANTES CARDIACOS, PARA EL TRATAMIENTO DEL FALLO CARDIACO.COMPRENDE LA REACCION DE UN COMPUESTO, DE FORMULA (II), CON UN COMPUESTO DE FORMULA (III), EN LAS QUE Q ES UN GRUPO SALIENTE Y X E Y TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, TAL COMO ETANOL, EN PRESENCIA DE UNA BASE NO NUCLEOFILA, TAL COMO UNA AMINA TERCIARIA, A UNA TEMPERATURA INFERIOR A LA DE REFLUJO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838320958A GB8320958D0 (en) | 1983-08-03 | 1983-08-03 | Quinazoline cardiac stimulants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8507536A1 true ES8507536A1 (es) | 1985-09-01 |
| ES534824A0 ES534824A0 (es) | 1985-09-01 |
Family
ID=10546755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES534824A Granted ES534824A0 (es) | 1983-08-03 | 1984-08-02 | Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4542132A (es) |
| EP (1) | EP0135318B1 (es) |
| JP (1) | JPS6069081A (es) |
| KR (1) | KR870000905B1 (es) |
| AU (1) | AU555482B2 (es) |
| CS (1) | CS253714B2 (es) |
| DD (1) | DD223452A5 (es) |
| DE (1) | DE3472677D1 (es) |
| DK (1) | DK375584A (es) |
| ES (1) | ES534824A0 (es) |
| FI (1) | FI843047A7 (es) |
| GB (1) | GB8320958D0 (es) |
| GR (1) | GR82659B (es) |
| HU (1) | HUT37421A (es) |
| IL (1) | IL72562A (es) |
| NO (1) | NO158941C (es) |
| NZ (1) | NZ209095A (es) |
| PH (1) | PH20835A (es) |
| PL (1) | PL249025A1 (es) |
| PT (1) | PT79001B (es) |
| YU (1) | YU135884A (es) |
| ZA (1) | ZA845944B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| FR2582513B1 (fr) * | 1985-05-28 | 1988-08-05 | Synthelabo | Compositions pharmaceutiques contenant de l'alfuzosine |
| EP0669324A4 (en) * | 1993-09-10 | 1996-04-03 | Eisai Co Ltd | CHINAZOLIN DERIVATIVES. |
| US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) * | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| JP2009213594A (ja) * | 2008-03-10 | 2009-09-24 | Okamura Chikuzai:Kk | 葬祭用祭壇装置 |
| CN104860870A (zh) * | 2014-02-26 | 2015-08-26 | 欧美嘉股份有限公司 | 具有不同取代基的哌啶的制备方法 |
| CN118878466A (zh) * | 2020-01-31 | 2024-11-01 | 特里纳普克公司 | 三氟唑及其制备方法 |
| US11314266B2 (en) | 2020-07-08 | 2022-04-26 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11256273B2 (en) | 2020-07-08 | 2022-02-22 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11131158B1 (en) | 2020-07-08 | 2021-09-28 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11274501B2 (en) | 2020-07-08 | 2022-03-15 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11294401B2 (en) | 2020-07-08 | 2022-04-05 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
| US11802645B2 (en) | 2020-07-08 | 2023-10-31 | Saudi Arabian Oil Company | Flow management systems and related methods for oil and gas applications |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| US4101548A (en) * | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
| IN148482B (es) * | 1977-06-03 | 1981-03-07 | Pfizer | |
| US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
| US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
-
1983
- 1983-08-03 GB GB838320958A patent/GB8320958D0/en active Pending
-
1984
- 1984-07-30 DE DE8484305151T patent/DE3472677D1/de not_active Expired
- 1984-07-30 EP EP84305151A patent/EP0135318B1/en not_active Expired
- 1984-07-30 PT PT79001A patent/PT79001B/pt unknown
- 1984-07-31 JP JP59161498A patent/JPS6069081A/ja active Pending
- 1984-07-31 US US06/636,197 patent/US4542132A/en not_active Expired - Lifetime
- 1984-07-31 GR GR75460A patent/GR82659B/el unknown
- 1984-08-01 PH PH31057A patent/PH20835A/en unknown
- 1984-08-01 DD DD84265888A patent/DD223452A5/de unknown
- 1984-08-01 FI FI843047A patent/FI843047A7/fi not_active Application Discontinuation
- 1984-08-01 YU YU01358/84A patent/YU135884A/xx unknown
- 1984-08-01 PL PL24902584A patent/PL249025A1/xx unknown
- 1984-08-01 IL IL72562A patent/IL72562A/xx unknown
- 1984-08-01 ZA ZA845944A patent/ZA845944B/xx unknown
- 1984-08-02 HU HU842948A patent/HUT37421A/hu unknown
- 1984-08-02 AU AU31419/84A patent/AU555482B2/en not_active Ceased
- 1984-08-02 NZ NZ209095A patent/NZ209095A/xx unknown
- 1984-08-02 NO NO843117A patent/NO158941C/no unknown
- 1984-08-02 ES ES534824A patent/ES534824A0/es active Granted
- 1984-08-02 DK DK375584A patent/DK375584A/da not_active Application Discontinuation
- 1984-08-02 KR KR1019840004616A patent/KR870000905B1/ko not_active Expired
- 1984-08-03 CS CS845918A patent/CS253714B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0135318A1 (en) | 1985-03-27 |
| ES534824A0 (es) | 1985-09-01 |
| KR850001746A (ko) | 1985-04-01 |
| CS591884A2 (en) | 1987-05-14 |
| GB8320958D0 (en) | 1983-09-07 |
| PL249025A1 (en) | 1985-08-27 |
| CS253714B2 (en) | 1987-12-17 |
| IL72562A0 (en) | 1984-11-30 |
| GR82659B (es) | 1985-02-07 |
| EP0135318B1 (en) | 1988-07-13 |
| US4542132A (en) | 1985-09-17 |
| ZA845944B (en) | 1986-07-30 |
| DK375584D0 (da) | 1984-08-02 |
| YU135884A (en) | 1986-10-31 |
| PH20835A (en) | 1987-04-30 |
| DK375584A (da) | 1985-02-04 |
| NO158941B (no) | 1988-08-08 |
| FI843047A7 (fi) | 1985-02-04 |
| PT79001B (en) | 1986-10-23 |
| NO158941C (no) | 1988-11-16 |
| JPS6069081A (ja) | 1985-04-19 |
| HUT37421A (en) | 1985-12-28 |
| KR870000905B1 (ko) | 1987-05-04 |
| AU555482B2 (en) | 1986-09-25 |
| IL72562A (en) | 1987-03-31 |
| PT79001A (en) | 1984-08-01 |
| DE3472677D1 (de) | 1988-08-18 |
| NO843117L (no) | 1985-02-04 |
| FI843047A0 (fi) | 1984-08-01 |
| DD223452A5 (de) | 1985-06-12 |
| NZ209095A (en) | 1986-11-12 |
| AU3141984A (en) | 1985-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2067456T3 (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende. | |
| ES8205789A1 (es) | Un procedimiento para la preparacion de derivados del indol | |
| CO4900063A1 (es) | Piridinas substituidas como inhibidores selectivos de ciclo- oxi-genasa2 | |
| ES8507534A1 (es) | Procedimiento para la preparacion de derivados benzopiranicos | |
| ES8605506A1 (es) | Procedimiento para preparar derivados de piperidina | |
| ES8306750A1 (es) | Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles. | |
| ES8801618A1 (es) | Un procedimiento para preparar derivados de arilciclobutilalquilamina | |
| ES8201583A1 (es) | Un procedimiento para la preparacion de derivados de triazo-lopiridazina | |
| ES2069281T3 (es) | Derivado de fenantreno. | |
| ES8706654A1 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
| ES8404317A1 (es) | Metodo de preparar aminoaminoacidos y analogos. | |
| ES8704468A1 (es) | Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos | |
| ES8301883A1 (es) | Procedimiento para la preparacion de derivados de ciclohexe-no | |
| AR019256A1 (es) | Utilizacion de derivados tetraciclo[6-6-2-0(2.27).0(9.14)] hexadeca-2(7), 3, 5, 9(14), 10,12-hexaeno, para la preparacion de preparados farmaceuticos conaccion inhibitoria de la fosfolipasa, los referidos derivados y preparado farmaceutico que contiene por lo menos a uno de dichos derivados | |
| ES8800193A1 (es) | Procedimiento para preparar 2,4-difenil-1,3-dioxanos | |
| ES2068497T3 (es) | Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen. | |
| ES8702385A1 (es) | Un procedimiento para preparar un compuesto heterociclico nitrogenado | |
| ES8706644A1 (es) | Un procedimiento para preparar derivados de dihidropiridazina | |
| AR007937A1 (es) | Un compuesto derivado de bencimidazole, un procedimiento para prepararlo, un medicamento constituido por dicho compuesto y una composicion farmaceuticaque comprende dicho compuesto | |
| ES8707923A1 (es) | Procedimiento para la obtencion de benzamidas | |
| ES8403465A1 (es) | Un procedimiento para preparar derivados de pirimidona. | |
| ES8204415A1 (es) | Un procedimiento para la preparacion de derivados de carboximidamida. | |
| ES2067447T3 (es) | Compuesto de penemo, produccion y uso del mismo. | |
| ES2059374T3 (es) | Substancia 4181-2 y sus derivados. | |
| ES8504792A1 (es) | Un procedimiento para preparar derivados de pirimidina |